Functions of dystrophin and dystrophin associated proteins

Current Opinion in Neurology

Volumn 10, Issue 5, 1997, Pages 436-442

  Michalak, Marek ^a   Opas, Michal ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DYSTROPHIN; GENE PRODUCT; GLYCOPROTEIN; MUSCLE PROTEIN; UTROPHIN;

BECKER MUSCULAR DYSTROPHY; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; EXTRACELLULAR MATRIX; GENE; GENE FUNCTION; GENE MUTATION; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT; REVIEW;

EID: 0030802652     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199710000-00014     Document Type: Review

References (79)

1. Worton R: Muscular dystrophies: diseases of the dystrophin-glycoprotein complex. Science 1995, 270:755-756.
2. Campbell KP: Three muscular dystrophies: loss of cytoskeletal-extracellular matrix. Cell 1995, 80:675-679.
3. Beckmann JS, Bushby KMD: Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy. Curr Opinion Neurol 1996, 9:389-393.
4. Sunada Y, Campbell KP: Dystrophin-glycoprotein complex: molecular organization and critical role in skeletal muscle. Curr Opinion Neurol 1995, 8:379-384.
5. Ohlendieck K: Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. Eur J Cell Biol 1996, 69:1-10. An excellent and comprehensive review on the structure and function of DGC is provided.
6. Winder SJ: Structure-function relationship in dystrophin and utrophin. Biochem Soc Trans 1996, 24:497-501. This is an interesting review on the structure and function of dystrophin.
7. Blake DJ, Tinsley JM, Davies KE: Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 1996, 6:37-47. This is an important review on utrophin.
8. 2- binding to the C-terminus ot dystrophin is provided.
9. Rybakova IN, Amann KJ, Ervasti JM: A new model for the interaction between dystrophin with F-actin. J Cell Biol 1996, 135:661-672. This is a thorough biochemical and biophysical analysis of F-actin binding to dystrophin, in which a new actin binding site in the middle region of dystrophin is indentified.
10. Yang B, Jung D, Rafael JA, Chamberlain JS, Campbell KP: Identification of α-syntrophin binding to syntrophin triplet, dystrophin, and utrophin. J Biol Chem 1995, 270:4975-4978.
11. Ahn AH, Kunkel LM: Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol 1995, 128:363-371.
12. Ahn AH, Freener CA, Gussoni E, Yoshida M, Ozawa E, Kunkel LM: The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J Biol Chem 1996, 271:2724-2730.
13. Henry MD, Campbell KP: Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol 1996, 8:625-631. A superb review on the structure and function of dystroglycan is presented.
14. Ponting CP, Blake DJ, Davies KE, Kendrick-Jones J, Winder SJ: ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem Sci 1996, 21:11-13.
15. Bork P, Sudol M: The WW domain: a signalling site in dystrophin? Trends Biochem Sci 1994, 19:531-533.
16. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP: Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem 1995, 270:27305-27310.
17. Rafael JA, Cox GA, Corrado K, Jung D, Campbell KP, Chamberlain JS: Forced expression of dystrophin deletion constructs reveals structure-function correlations. J Cell Biol 1996, 134:93-102. This is a comprehensive analysis of the function of the C-terminal region of dystrophin using transgenic techniques.
18. Corrado K, Rafael JA, Mills PL, Cole NM, Faulkner JA, Wang K, Chamberlain JS: Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype. J Cell Biol 1996, 134:873-884. This paper documents application of transgenic technique to investigate a role of N-terminal domain of dystrophin.
19. Cox GA, Sunada Y, Campbell KP, Chamberlain JS: Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nature Genet 1994, 8:333-339.
20. Greenberg DS, Sunada Y, Campbell KP, Yaffe O, Nudel U: Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nature Genet 1994, 8:340-344.
21. Luise M, Presotto C, Senter L, Betto R, Ceddo S, Furlan S, Salvatori S, Sabbadini RA, Salviati G: Dystrophin is phosphorylated by endogenous protein kinases. Biochem J 1993, 293:243-247.
22. Madhavan R, Jarrett HW: Calmodulin-actlvated phosphorylation of dystrophin. Biochemistry 1995, 33:5797-5804.
23. 2+-calmodulin binds to the carboxyl-terminal domain of dystrophin. J Biol Chem 1996, 271:6605-6610.
24. Ahn AH, Kunkel LM: The structural and functional diversity of dystrophin. Nature Genet 1993, 3:283-291.
25. Fabbrizio E, Pons F, Robert A, Hugon G, Bonet-Kerrache A, Mornet D: The dystrophin superfamily: variability and complexity. J Muscle Res Cell Motility 1994, 15:595-606.
26. D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA, Ray PN: A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 1995, 4:837-842.
27. Lidov HGW, Selig S, Kunkel LM: Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet 1995, 4:329-335.
28. Campanelli JT, Roberds SL, Campbell KP, Scheller R: A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AchR clustering. Cell 1994, 77:663-674.
29. Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S: Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 1994, 77:675-686
30. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davis KE: Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 1996, 284:349-353. A report of the discovery that utrophin can effectively rescue dystrophin deficient muscle in vivo is presented. This is a major step towards gene therapy.
31. Gramolini AO, Dennis CL, Tinsley JM, Robertson GS, Cartaud J, Davis KE, Jasmin BJ: Local transcriptional control of utrophin expression at the neuromuscular synapse. J Biol Chem 1997, 272:8117-8120. This paper documents a very important discovery of a possible role of nerve-derived growth factor(s) in control of transactivation of the utrophin gene. This information might be essential for a successful use of utrophin for gene therapy.
32. Karpati G: Utrophin muscles in on the action. Nature Med 1997, 3:22-23.
33. Campbell KP, Crosbie RH: Utrophin to the rescue. Nature 1996, 384:308-309.
34. Roberts RG, Greeman TC, Kendall E, Vetrie DLP, Dixon AK, Shaw-Smith C, Bone Q, Bobrow M: Characterization of DRP2, a novel human dystrophin homologue. Nature Genet 1996, 13:223-226. The identification of a new dystrophin-like protein, DRP2, is presented.
35. Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, Kanazawa I, Kobata A, Endo T: Structures of silylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. J Biol Chem 1997, 272:2156-2162.
36. Yang B, Jung D, Mott D, Meyer J, Koretzky G, Campbell KP: SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 1995, 270:11711-11714.
37. Glass DJ, Bowen DC, Stitt TN, Radziejowski C, Bruno J, Ryan TE, Gies DR, Shah S, Mattsson K, Burden SJ et al.: Agrin acts via a MuSK receptor complex. Cell 1996, 85:513-523.
38. Gesemann M, Cavalli V, Denzer AJ, Brancaccio A, Schumacher B, Ruegg MA: Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor. Neuron 1996, 16:755-767.
39. DeChiara TM, Bowen DC, Valenzueal DM, Simmons MV, Poueymirou WT, Thomas S, Kintz E, Compton DL, Rojas E, Park JS et al.: The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 1996, 85:501-512.
40. Hopf C, Hoch W: Agrin binding to α-dystroglycan. J Biol Chem 1996, 271:5231-5236.
41. Meier T, Gesemann M, Cavalli V, Ruegg MA, Wallace BG: AChR phosphorylation and aggregation induced by agrin fragment that lacks the binding domain for α-dystroglycan. EMBO J 1996, 15:2625-2631.
42. Ferns M, Deiner M, Hall Z: Agrin-induced acetylcholine receptor clustering in mammalian muscle requires tyrosine phosphorylation. J Cell Biol 1996, 132:937-944.
43. Cohen MW, Jacobson C, Yurchenco PD, Morris GE, Carbonetto S: Laminin-induced clustering of dystroglycan on embryonic muscle cells: comparison with agrin-induced clustering. J Cell Biol 1997, 136:1047-1058. This is the first report on laminin dependent clustering of dystroglycan, which might be important to our understanding of its assembly into the DGC.
44. ••].
45. ••] this work describes the discovery, molecular cloning and detailed biochemical analysis of the δ-sarcoglycan.
46. ••]).
47. McNally EM, Duggan D, Gorospe JR, Bonnemann CG, Fanin M, Pegoraro E, Lidov HGW, Naguchi S, Ozawa E, Finkel RS et al.: Mild and severe muscular dystrophy caused by a single γ-sarcoglycan mutation. Am J Hum Genet 1996, 59:1040-1047.
48. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C et al.: Mutations in the proteolytic enzyme calpainS cause limb-gridle muscular dystrophy type 2A. Cell 1995, 81:27-40.
49. ••]).
50. Salih MAM, Sunada Y, AI-Nasser M, Ozo CO, AI-Turaiki HS, Akbar M, Campbell KP: Muscular dystrophy associated with β-dystroglycan deficiency. Ann Neurol 1996, 40:925-928. This is the first identification of muscular dystrophy associated with a β-dystroglycan deficiency.
51. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J Biol Chem 1996, 271:15160-15165. This paper documents recognition of a possible identity between caveolin-3 and a 25 kDa component of the DGC, which indicates that the DGC might be involved in signal transduction.
52. Gibson TJ, Hyvonen M, Musacchio A, Saraste M, Birney E: PH domain. The first aniversary. Trends Biochem Sci 1994, 19:349-353.
53. •].
54. •] the molecular cloning of new isoforms of dystrobrevins.
55. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS: Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 1995, 82:743-752.
56. Chang W-J, Iannaccone ST, Lau KS, Masters BSS, McCabe TJ, McMillan K, Padre RC, Spencer MJ, Tidball JG, Stull JT: Neuronal nitric oxide and dystroph in-deficient muscular dystrophy. Proc Natl Acad Sci U S A 1996, 93:9142-9147.
57. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993, 90:3710-3714.
58. Pasternak C, Wong S, Elson EL: Mechanical function of dystrophin in muscle cells. J Cell Biol 1995, 128:355-361.
59. Stevenson S, Rothery S, Cullen MJ, Severs NJ: Dystrophin is not a specific component of the cardiac costamere. Circ Res 1997, 80:269-280.
60. Burridge K, Chrzanowska-Wodnicka M: Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996, 12:463-518.
61. Craig SW, Johnson RP: Assembly of focal adhesions: progress, paradigms, and portents. Curr Opin Cell Biol 1996, 8:74-85.
62. Ingber DE: Tensegrity: the architectural basis of cellular mechano-transduction. Annu Rev Physiol 1997, 59:575-599.
63. Pardo JV, Siliciano JD, Craig SW: A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci USA 1983, 80:1008-1012.
64. Danowski BA, Imanaka-Yoshida K, Sanger JM, Sanger JW: Costameres are sites of force transmission to the substratum in adult rat cardiomyocytes. J Cell Biol 1992, 118:1411-1420.
65. Byers TJ, Kunkel LM, Watkins SC: The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle. J Cell Biol 1991, 115:411-421.
66. Klietsch R, Ervasti JM, Arnold W, Campbell KP, Jorgensen AO: Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle. Circ Res 1993, 72:349-360.
67. North AJ, Galazkiewicz B, Byers TJ, Glenney JR Jr, Small JV: Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle. J Cell Biol 1993, 120:1159-1167.
68. Meng H, Leddy JJ, Frank J, Holland P, Tuana BS: The association of cardiac dystrophin with myofibrils/Z-disc regions in cardiac muscle suggests a novel role in the contractile apparatus. J Biol Chem 1996, 271:12364-12371.
69. Law DJ, Caputo A, Tidball JG: Site and mechanics of failure in normal and dystrophin-deficient skeletal muscle. Muscle Nerve 1995, 18: 216-223.
70. Straub V, Bittner RE, Leger JJ, Voit T: Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J Cell Biol 1992, 119:1183-1191.
71. Carpenter S, Karpati G, Zubrzycka-Gaarn E, Bulman DE, Ray PN, Worton RG: Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron-microscopic cytochemical study. Muscle Nerve 1990, 13:376-380.
72. Katoh K, Kano Y, Masuda M, Fujiwara K: Mutually exclusive distribution of the focal adhesion associated proteins and the erythrocyte membrane skeleton proteins in the human fibroblast plasma membrane undercoat. Cell Struct Funct 1996, 21:27-39.
73. Couchman JR, Rees DA: The behaviour of fibroblasts migrating from chick heart explants: changes in adhesion, locomotion and growth, and in the distribution of actomyosin and fibronectin. J Cell Sci 1979, 39:149-165.
74. Chen W-T, Singer SJ: Immunoelectron microscopic studies of the sites of cell-substratum and cell-cell contacts in cultured fibroblasts. J Cell Biol 1982, 95:205-222.
75. Witkowski JA, Dubowitz V: Duchenne muscular dystrophy: studies of cell motility in vitro. J Cell Sci 1985, 76:225-234.
76. Lark MW, Laterra J, Culp LA: Close and focal contact adhesions of fibroblasts to a fibronectin-containing matrix. Fed Proc 1985, 44:394-403.
77. Franco-Obregon A Jr, Lansman JB: Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice. J Physiol 1994, 481:299-309.
78. McNeil PL, Steinhardt RA: Loss, restoration, and maintenance of plasma membrane integrity. J Cell Biol 1997, 137:1-4.
79. Brown SC, Lucy JA: Dystrophin as a mechanochemical transducer in skeletal muscle. BioEssays 1993, 15:413-419.